Principal Financial Group
SBBP

Principal Financial Group’s Strongbridge Biopharma plc. SBBP Stock Holding History

Principal Financial Group’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-93,064
Closed -$190K – 2718
2021
Q3 		$190K Sell
93,064
-692
-0.7% -$1.61K ﹤0.01% 2438
2021
Q2 		$278K Buy
93,756
+45,049
+92% +$119K ﹤0.01% 2384
2021
Q1 		$134K Sell
48,707
-6,504
-12% -$19.6K ﹤0.01% 2407
2020
Q4 		$134K Buy
+55,211
New +$133K ﹤0.01% 2341

Principal Financial Group's SBBP Position: Q4 2021 in Review

Principal Financial Group sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 93,064 shares — an estimated $190K sold.

Principal Financial Group first reported a position in SBBP in Q4 2020 and held it in 4 quarters. The position peaked at $278K in Q2 2021. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

  • Principal Financial Group reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
  • Principal Financial Group sold 93,064 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $190K.
  • Principal Financial Group first reported a position in Strongbridge Biopharma plc. in Q4 2020 and held it in 4 quarters.
  • Principal Financial Group's Strongbridge Biopharma plc. position peaked at $278K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on Principal Financial Group's 13F filing for Q4 2021, filed 9 Feb 2022.